Collaboration with Innovative Partners
in Fibrosis and Spatial biology
Accelerate Tissue-based Assay Development with ViQi's AI-Powered Platform
ViQi's AI-driven platform is revolutionizing tissue analysis. We partner with industry leaders like Akoya Biosciences and PharmaNest to develop cutting-edge solutions for digital pathology.
The unique advantages of the ViQi platform lie in the tight integration of unparalleled, state-of-the-art visualization and annotation, large scale AI-enabled analysis, flexible data management and expert guidance by our team.
Advantages
Key Benefits
Rapid Development: Dramatically accelerate assay development with our team’s expertise and collaborative SaaS platform.
High-Throughput Analysis: Analyze large batches of slides quickly and efficiently with our automation tools and scalable platform.
Industry-Leading Accuracy: Achieve unmatched precision with AI-powered scoring for fibrosis and spatial biology assays.
Versatile Applications: Analyze brightfield digital slides with various stains (H&E, Picrosirius Red, IHC) or highly multiplexed fluorescent data.
Seamless Transition: Simplify production with our FDA MDDS designation.
Powerful Visualization: Visualize and annotate every aspect of your pipeline in one place.
Unlock Precision, Accelerate Discovery
Fibronest
ViQi and PharmaNest: A Powerful Partnership Driving Innovation in Fibrosis Research
ViQi and PharmaNest proudly present FibroNest™, a game-changing AI solution for digital pathology. This first-of-its-kind technology provides multi-vendor compatibility and fully translational quantitative AI for phenotypic quantification of fibrosis and its associated features for research and preclinical projects.
FibroNest™
In a recent Phase 3 trial with Galmed's Aramchol, FibroNest™ delivered unparalleled sensitivity in quantifying antifibrotic effects, surpassing traditional pathology methods.
ViQi's FDA MDDS designation reinforces the reliability of FibroNest™, supporting PharmaNest's pursuit of regulatory approval for its digital pathology biomarker.
Single-fiber detection and phenotyping
Cell Phenotyping
Fibrosis and steatosis detection
Tumor detection
Spatial Biology, Accelerated:
ViQi and Akoya Biosciences Redefine Speed
and Scale
Experience the future of spatial biology with the groundbreaking partnership between ViQi and Akoya Biosciences.
This innovative platform, based on Akoya's highly-multiplexed data, enables spatial phenotyping of every cell across whole slides.
Akoya's pipeline leverages the advanced visualization, metadata, annotation, and analysis capabilities of ViQi's platform while running Akoya's custom, proprietary analysis algorithms.
Akoya's operational needs demand automation, and ViQi's platform excels in this area by blending advanced automated analysis with simplified user validation. This has reduced Akoya's pipeline processing time from weeks to days and significantly improved efficiency for human operators.
Akoya CODEX 5 channel multiplexed image visualization example
Cell segmentation overlay colored by the neighborhood density feature
